The incidence of herpes zoster in China: A meta-analysis and evidence quality assessment

References

• Cohen JI, Brunell PA, Straus SE. Recent advances in varicella-zoster virus infection. Annals of internal medicine. 1999;130(11):922–9. doi:10.7326/0003-4819-130-11-199906010-00017.
   PubMed Web of Science ®Google Scholar
• Gnann JJW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340–6. doi:10.1056/nejmcp013211.
   PubMed Web of Science ®Google Scholar
• McElhaney JE. Herpes zoster: a common disease that can have a devastating impact on patients’ quality of life. Expert Rev Vaccines. 2010;9(sup3):27–30. doi:10.1586/erv.10.31.
   PubMed Web of Science ®Google Scholar
• Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9(sup3):21–6. doi:10.1586/erv.10.30.
   PubMed Web of Science ®Google Scholar
• Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, et al. A systematic literature review to assess the burden of herpes zoster disease in China. Expert Rev Anti Infect Ther. 2021;19(2):165–79. doi:10.1080/14787210.2020.1792290.
   PubMed Web of Science ®Google Scholar
• Sun Y, Kim E, Kong CL, Arnold BF, Porco TC, Acharya NR. Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study. Clin Infect Dis. 2021;73(6):949–56. doi:10.1093/cid/ciab121.
   PubMed Web of Science ®Google Scholar
• Katz SL. Varicella and herpes zoster vaccines WHO position paper，June 2014. Wkly Epidemiol Rec. 2014;89:265–87.
   PubMedGoogle Scholar
• Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang S-J, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96. doi:10.1056/NEJMoa1501184.
   PubMed Web of Science ®Google Scholar
• Miller ER, Lewis P, Shimabukuro TT, et al. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015. Hum Vaccin Immunother. 2018;14(8):1963–9. doi:10.1080/21645515.2018.1456598.
   PubMed Web of Science ®Google Scholar
• National Medical Products Administration. Recombinant zoster vaccine are launched[EB/OL]. [accessed 2019 May 22]. https://www.nmpa.gov.cn/directory/web/nmpa/zhuanti/ypqxgg/gggzjzh/20190522150701437.html.
   Google Scholar
• Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O’Connell D, Oxman AD, Phillips B, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE working group. BMC Health Serv Res. 2004;4(1):1–7. doi:10.1186/1472-6963-4-38.
   PubMedGoogle Scholar
• Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. doi:10.1016/j.jclinepi.2010.04.026.
   PubMed Web of Science ®Google Scholar
• Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Bossuyt P, Chang S, Muti P, Jaeschke R, Guyatt GH. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med. 2008;13(6):162–3. doi:10.1136/ebm.13.6.162-a.
   PubMedGoogle Scholar
• Schünemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Sys. 2006;4(1):21. doi:10.1186/1478-4505-4-21.
   PubMedGoogle Scholar
• Migliavaca CB, Stein C, Colpani V, Barker TH, Munn Z, Falavigna M. How are systematic reviews of prevalence conducted? BMC Med Res Methodol. 2020. doi: 10.1186/s12874-020-00975-3.
   Web of Science ®Google Scholar
• Deng H, Liu F. Epidemiological characteristics of herpes zoster and research progress of vaccine immunization program in China. China Contin Med Educ. 2021;13(19):4. doi:10.3969/j.issn.1674-9308.2021.19.039.
   Google Scholar
• Feng L, Yang T, Wang Q, Yang Y, Leng ZW, Chen SY, Jia MM, Zhang T, Chen FY, Zhang XX, et al. Prevent infectious diseases through vaccination, and protect health of the elderly. National Med J China. 2020;100(48):3821–6. doi:10.3760/cma.j.cn112137-20201020-02882.
   Google Scholar
• Mark Vrabel MLS. Preferred reporting items for systematic reviews and meta-analyses[C]//Oncology nursing forum. Oncol Nurs Soc. 2015;42(5):552. doi:10.1188/15.ONF.552-554.
   Google Scholar
• Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19:170–6.
   PubMedGoogle Scholar
• Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2):37–9. doi:10.1136/ebmh.1.2.37.
   Google Scholar
• Jekel JF, Katz DL, Elmore JG. Epidemiology, biostatistics and preventive medicine. USA: Elsevier Health Sciences; 2007.
   Google Scholar
• Streiner DL, Norman GR. PDQ epidemiology. USA: People's Medical Publishing House; 2009.
   Google Scholar
• Deeks J, Higgins J, Altman D. Analyzing data and undertaking meta-analyses. In: Cochrane handbook for systematic reviews of interventions: Cochrane book series. Wiley-Blackwell; 2008. doi:10.1002/9780470712184.
   Google Scholar
• Wang D, Mou Z, Zhai J, Zong HX, Zhao XD. Application of Stata software to heterogeneity test in meta-analysis. Chin J Epidemiol. 2008;29(7):4.
   Google Scholar
• Wang D, Mou Z, Zhai J, Zong HX., Zhao XD. Study on Stata software in investigating publication bias in meta-analysis. Mod Prev Med. 2008;35(15):4. doi:CNKI:SUN:XDYF.0.2008-15-002.
   Google Scholar
• Zhang Z, Suo L, Pan J, Zhao D, Lu L. Two-dose varicella vaccine effectiveness in China: a meta-analysis and evidence quality assessment. BMC Infect Dis. 2021;21(1):543. doi:10.1186/s12879-021-06217-1.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6. doi:10.1136/bmj.39489.470347.AD.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, et al. GRADE guidelines. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311–16. doi:10.1016/j.jclinepi.2011.06.004.
   PubMed Web of Science ®Google Scholar
• Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6. doi:10.1016/j.jclinepi.2010.07.015.
   PubMed Web of Science ®Google Scholar
• Suo L, Wang Y, Pang X, Wang YC, Wang Q, Wang HH, Peng XH, Wang X, Zhu ZL, Wang YF, Pang XH. Analysis of herpes zoster incidence and hospitalization in three areas of Beijing in 2015 based on health information system of medical institutions. Chin J Prev Med. 2019;53(5):503–7. doi:10.3760/cma.j.issn.0253-9624.2019.05.013.
   Google Scholar
• Wang Q, Zhou M, Sun H. Epidemiological characteristics of herpes zoster in Xicheng District of Beijing in 2019: based on the health information system of medical institutions. Chin J Epidemiol. 2021;42(12):4. doi:10.3760/cma.j.cn112338-20210706-00523.
   Google Scholar
• Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect. 2012;140(6):1131–40. doi:10.1017/S0950268811001786.
   PubMed Web of Science ®Google Scholar
• Jiang W, Li G, Xu Y, Pei S, Yan Y, Tong H, Wang W, Xu C, Liu Y, Yin D. Epidemiological characteristics of herpes zoster in urban areas of Yichang city during 2016-2017 based on the Yichang Big Data platform for health management. Chin J Vaccines Immun. 2019;25(4):4.
   Google Scholar
• Zhao L, Wang HT, Ye RZ, Li Z-W, Wang W-J, Wei J-T, Du W-Y, Yin C-N, Wang S-S, Liu J-Y, et al. Profile and dynamics of infectious diseases: a population-based observational study using multi-source big data. BMC Infect Dis. 2022;22(1):1–12. doi:10.1186/s12879-022-07313-6.
   PubMed Web of Science ®Google Scholar
• Lu L, Suo L, Li J, Pang, X. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Hum Vaccin Immunother. 2018;14(11):2632–5. doi:10.1080/21645515.2018.1489193.
   PubMed Web of Science ®Google Scholar
• Ding X, Jiang W, Hu Y, Jiang J, Wu Y, Xu CZ, Wu ZZ, Yu YF, Liu XJ, Li GW, et al. Study on the incidence of adult herpes zoster in Yichang city and its association with early‑life famine exposure. Chin J Prev Med. 2021;55(11):4. doi:10.3760/cma.j.cn112150-20201110-01350.
   Google Scholar
• Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: data from an integrated health care network. J Infect. 2021;82(2):253–60. doi:10.1016/j.jinf.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zheng H, Qu H, Deng H, Zhang J, Ma W, Lin Y, Xie X, Qiu Q, Huang Z, et al. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015;11(8):2113–8. doi:10.1080/21645515.2015.1016672.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Xu J, Ma Y, Tu Q, Li Q, Wang H, et al. Disease burden due to herpes zoster among population aged ≥50 years old in China: a community based retrospective survey. PLoS One. 2016;11(4):e0152660. doi:10.1371/journal.pone.0152660.
   PubMed Web of Science ®Google Scholar
• Zang X, Li YF, Sun Y, Pan J, Zhao D, Lu L. Cross-sectional study on herpes zoster among adults aged 45 and above in Xiamen and Dongtai. Chin Primary Health Care. 2019;33(9):59–62. doi:10.3969/j.issn.1001-568X.2019.09.0021.
   Google Scholar
• Zhang W, Liu S, Sun H, Wang HY, Luan GJ, Sun L, Xu AQ. Study of incidence and economic burden of herpes zoster based on community investigation among the aged in Laiwu district, Jinan city, Shandong Province of China. Chin J Prev Med. 2022;56(2):6. doi:10.3760/cma.j.cn112150-20211125-01085.
   Google Scholar
• Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8(1):1–9. doi:10.1186/1471-2288-8-79.
   PubMedGoogle Scholar
• Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, et al. GRADE guidelines: 7. Rating the quality of evidence—inconsistency. J Clin Epidemiol. 2011;64(12):1294–302. doi:10.1016/j.jclinepi.2011.03.017.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, Sauver JLS, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–9. doi:10.4065/82.11.1341.
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post⁃herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38–47. doi:10.1017/S0950268808000678.
   PubMed Web of Science ®Google Scholar
• Coplan P, Black S, Rojas C, Shinefield H, Ray P, Lewis E, Guess H. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J. 2001;20(7):641–5. doi:10.1097/00006454-200107000-00002.
   PubMed Web of Science ®Google Scholar
• Gonzalez CS, Sarazin M, Turbelin C, Lasserre A, Pelat C, Bonmarin I, Chosidow O, Blanchon T, Hanslik T. Herpes zoster: burden of disease in France. Vaccine. 2010;28(50):7933–8. doi:10.1016/j.vaccine.2010.09.074.
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward J. Incidence of herpes zoster, before and after varicella-vaccination–associated decreases in the incidence of varicella, 1992–2002. J Infect Dis. 2005;191(12):2002–7. doi:10.1086/430325.
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics. Total population at the end of the year[EB/OL]. [accessed 2021 Dec 31]. https://data.stats.gov.cn/easyquery.htm?cn=C01.
   Google Scholar
• National Health Commission of the People’s Republic of China. Overview of national notifiable infectious diseases, 2021. [accessed 2022 Apr 22]. http://www.nhc.gov.cn/jkj/s3578/202204/4fd88a291d914abf8f7a91f6333567e1.shtml.
   Google Scholar
• Chen F, Liu G. Population aging in China. International handbook of population aging. Springer Science & Business Media; 2009. p. 157–72. doi:10.1007/978-1-4020-8356-3_8.
   Google Scholar
• Luo Y, Su B, Zheng X. Trends and challenges for population and health during population aging—China, 2015–2050. China CDC Weekly. 2021;3(28):593. doi:10.46234/ccdcw2021.158.
   PubMedGoogle Scholar
• Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R Risk factors for postherpetic neuralgia. Arch Intern Med. 1997;157(11):1217–24. doi:10.1001/archinte.1997.00440320117011.
   PubMedGoogle Scholar
• Bayas JM, Gil R, Llupià A, Díez C, Conesa A, Ariza C, Gil A, San Martín M. Hospitalizaciones por herpes zoster y neuralgia postherpética en Cataluña, 1998–2003. Vacunas. 2011;12(4):122–8. doi:10.1016/S1576-9887(11)70019-X.
   Google Scholar
• Gil A, Gil R, Alvaro A, San Martín M, González A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004). BMC Infect Dis. 2009;9(1):55. doi:10.1186/1471-2334-9-55.
   PubMedGoogle Scholar
• Brisson M, Edmunds WJ. Epidemiology of varicella zoster virus in England and Wales. J Med Virol. 2003;70(1):S9 14. doi:10.1002/jmv.10313.
   PubMedGoogle Scholar
• Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Med. 1982;61(5):310–6. doi:10.1097/00005792-198209000-00003.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan PC, Kurland MJ, St. Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88–93. doi:10.4065/mcp.2010.0618.
   PubMed Web of Science ®Google Scholar
• Qiu J, Sun X, Hu J. Willingness to receive herpes zoster vaccine and factors influencing willingness among≥50-year-old adults of Shanghai in May-June 2020. Chin J Vaccines Immun. 2021;27(3):5. doi:10.19914/j.CJVI.2021057.
   Google Scholar
• Huang SY, Song J-H, Xing LY. Willingness and influencing factors of herpes zoster vaccination among residents ≥50 years old in Zhengzhou. South China J Prev Med. 2022;48:4.
   Google Scholar
• Coplan PM, Schmader K, Nikas A, Chan ISF, Choo P, Levin MJ, Johnson G, Bauer M, Williams HM, Kaplan KM, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344–56. doi:10.1016/j.jpain.2004.06.001.
   PubMed Web of Science ®Google Scholar